Skip to main content
Cardiac Biotech Solutions Inc. (CBSC)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST

Cardiac Biotech Solutions Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
 TTM FY 2018 FY 2017
Period Ending
 Dec '18 Mar '18 Mar '17
Net Income
--1.13-0.39
Depreciation & Amortization
-00
Change in Accounts Receivable
--00.01
Change in Inventory
-0.02-0
Change in Accounts Payable
-0.020.13
Change in Other Net Operating Assets
-0.320.18
Operating Cash Flow
--0.77-0.06
Capital Expenditures
--0-0
Sale (Purchase) of Intangibles
--0-
Investing Cash Flow
--0.01-0
Short-Term Debt Issued
-0.360.08
Total Debt Issued
-0.360.08
Short-Term Debt Repaid
--0.28-
Total Debt Repaid
--0.28-
Net Debt Issued (Repaid)
-0.090.08
Issuance of Common Stock
-0.68-
Financing Cash Flow
-0.770.08
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
--0.010.01
Free Cash Flow
--0.77-0.06
Free Cash Flow Margin
--2109.05%-191.28%
Free Cash Flow Per Share
--0.01-0.00
Levered Free Cash Flow
--0.02-
Unlevered Free Cash Flow
--0.02-
Change in Working Capital
-0.360.32
Source: S&P Capital IQ. Standard template. Financial Sources.